Error message

User warning: The following module is missing from the file system: admin_menu. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /mnt/stor8-wc1-dfw1/408138/

Abba Medix Group Inc.

Abba Medix Group Enters into Definitive Agreement to Acquire Redecan Pharm. Redecan is focused on developing premium quality medical marijuana products and Redekop is a licensed producer and seller, able to cultivate marijuana under the Marihuana for Medical Purposes Regulations (“MMPR”) in Canada. Redekop obtained a medical marijuana license to undertake the production of medical marijuana in July 2014 and in March 2015 was awarded a full production and sales license. Redekop (also operating under the name Redecan Pharm), is currently listed as one of the seventeen persons in Canada to obtain such a license to date. Redekop has applied to Health Canada to transfer and assign his MMPR license to Redecan. If such transfer is approved, the principal focus of Redecan will be the production of medical marijuana from its fully secured, 15,000 square-foot greenhouse production facility in Niagara, Ontario. Abba Medix Group Inc. (“Abba”) (cse:ABA), formerly Saratoga Electronic Solutions Inc., is the parent company to Abba Medix Corp. which was established in August 2013 to capitalize on the dramatically changing rules governing medical marijuana production in Canada. Abba submitted its initial application under the MMPR licensing program in November of 2013. Abba’s 19,000 sq. ft. Pickering, Ontario growing facility, with an output capacity of 115 kg per month, is complete and ready for Health Canada inspection. It is currently awaiting approval from Health Canada to produce medical cannabis. Through Blow Vapor, Abba is providing customers with nothing but the best, most innovative products on the market, offering a wide collection of premium products to fit everyone’s lifestyle and vaping preferences.
Company Overview
Stock Overview